Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Using fat-derived stem cells for hair loss treatment is safe and effective, improving hair growth and patient satisfaction.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Some babies are born with alopecia areata, and a treatment with clobetasol propionate can regrow hair in half of the cases.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Immune cells affect hair growth and could lead to new hair loss treatments.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Platelet lysate is more effective than activated autologous platelet-rich plasma or saline in improving hair growth after hair restoration surgery.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Alopecia areata involves immune response and gene changes affecting hair loss.

Miniaturized hairs stay connected to muscle in alopecia areata, allowing possible regrowth, but not in androgenetic alopecia.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.